Hypocalcemia
Introduction
Hypocalcemia is a condition characterized by an abnormally low level of calcium in the blood. Calcium is a crucial mineral in the human body, playing a vital role in various physiological processes, including bone formation, muscle contraction, nerve function, and blood clotting. The normal range for serum calcium is typically between 8.5 and 10.5 mg/dL. When levels fall below this range, it can lead to a variety of clinical manifestations and complications.
Etiology
Hypocalcemia can result from a multitude of causes, which can be broadly categorized into disorders of parathyroid hormone (PTH) secretion, vitamin D deficiency, renal insufficiency, and other miscellaneous causes.
Parathyroid Hormone Disorders
Parathyroid hormone is a critical regulator of calcium homeostasis. Hypoparathyroidism, characterized by insufficient production of PTH, is a primary cause of hypocalcemia. This condition can be congenital, autoimmune, or post-surgical following thyroidectomy or parathyroidectomy. Pseudohypoparathyroidism, a genetic disorder, results in resistance to PTH despite normal or elevated hormone levels.
Vitamin D Deficiency
Vitamin D is essential for calcium absorption in the intestines. Deficiency can arise from inadequate dietary intake, insufficient sunlight exposure, malabsorption syndromes, or liver and kidney diseases that impair the conversion of vitamin D to its active form, calcitriol.
Renal Insufficiency
Chronic kidney disease (CKD) can lead to hypocalcemia through multiple mechanisms, including decreased production of calcitriol, hyperphosphatemia, and resistance to PTH. The impaired renal function reduces the kidneys' ability to convert vitamin D to its active form and to excrete phosphate, leading to secondary hyperparathyroidism and subsequent hypocalcemia.
Other Causes
Other causes of hypocalcemia include acute pancreatitis, rhabdomyolysis, severe sepsis, and certain medications such as bisphosphonates and anticonvulsants. Hypomagnesemia can also induce hypocalcemia by impairing PTH secretion and action.
Pathophysiology
The pathophysiology of hypocalcemia involves disruptions in the balance between calcium intake, absorption, and excretion, as well as alterations in the hormonal regulation of calcium homeostasis. PTH and vitamin D are the primary hormones involved in maintaining serum calcium levels. PTH increases calcium reabsorption in the kidneys, mobilizes calcium from bones, and stimulates the production of calcitriol, which enhances intestinal absorption of calcium. In hypocalcemia, these regulatory mechanisms are compromised, leading to decreased serum calcium levels.
Clinical Manifestations
The clinical presentation of hypocalcemia can vary widely, ranging from asymptomatic to severe, life-threatening symptoms. Common manifestations include neuromuscular irritability, cardiovascular abnormalities, and neuropsychiatric symptoms.
Neuromuscular Symptoms
Neuromuscular irritability is a hallmark of hypocalcemia and can present as paresthesias, muscle cramps, tetany, and seizures. Chvostek's sign (facial muscle twitching upon tapping the facial nerve) and Trousseau's sign (carpal spasm upon inflating a blood pressure cuff) are classic physical examination findings indicative of hypocalcemia.
Cardiovascular Symptoms
Hypocalcemia can lead to prolonged QT interval on electrocardiogram (ECG), which increases the risk of arrhythmias. Severe hypocalcemia can cause heart failure, hypotension, and even cardiac arrest.
Neuropsychiatric Symptoms
Patients with hypocalcemia may experience cognitive disturbances, depression, anxiety, and irritability. In severe cases, hypocalcemia can lead to confusion, delirium, and psychosis.
Diagnosis
The diagnosis of hypocalcemia involves a combination of clinical evaluation, laboratory tests, and imaging studies.
Laboratory Tests
Serum calcium levels are measured to confirm hypocalcemia. It is essential to correct the measured calcium level for albumin concentration, as hypoalbuminemia can lead to falsely low total calcium levels. Ionized calcium, the biologically active form, provides a more accurate assessment. Additional tests include serum PTH, vitamin D levels, magnesium, phosphate, and renal function tests.
Imaging Studies
Imaging studies, such as neck ultrasound or sestamibi scan, may be performed to evaluate parathyroid gland abnormalities. Bone density scans (DEXA) can assess the impact of chronic hypocalcemia on bone health.
Treatment
The management of hypocalcemia depends on the underlying cause, severity of symptoms, and the presence of any complications.
Acute Management
In cases of severe, symptomatic hypocalcemia, intravenous calcium gluconate is administered to rapidly correct serum calcium levels. Continuous cardiac monitoring is recommended due to the risk of arrhythmias.
Chronic Management
For chronic hypocalcemia, oral calcium supplements and vitamin D analogs are the mainstays of treatment. The choice of vitamin D preparation (cholecalciferol, ergocalciferol, or calcitriol) depends on the underlying etiology. Magnesium supplementation may be necessary in cases of concurrent hypomagnesemia.
Prognosis
The prognosis of hypocalcemia varies depending on the underlying cause and the promptness of treatment. Acute hypocalcemia can be life-threatening if not promptly addressed, but with appropriate management, most patients recover without long-term sequelae. Chronic hypocalcemia requires ongoing treatment and monitoring to prevent complications such as osteomalacia, osteoporosis, and nephrocalcinosis.
Prevention
Preventive measures for hypocalcemia include adequate dietary intake of calcium and vitamin D, regular sun exposure, and monitoring of at-risk populations, such as patients with chronic kidney disease or those on medications that affect calcium metabolism. Early detection and management of underlying conditions, such as hypoparathyroidism or malabsorption syndromes, are crucial in preventing hypocalcemia.
See Also
References
- To be added if available.